Blog Index
The journal that this archive was targeting has been deleted. Please update your configuration.

CLARENTIS contributes to Journal of Hospital Infection publication


October 2, 2016

Journal of Hospital Infection:
“Elimination of biofilm and microbial contamination reservoirs in hospital washbasin U-bends by automated cleaning and disinfection with electrochemically activated solutions*”.

J.S. Swan a, E.C. Deasy b, M.A. Boyle b, R.J. Russell c, M.J. O'Donnell b, D.C. Coleman b,

  • a - Facilities Department, Dublin Dental University Hospital, Lincoln Place, Dublin 2, Ireland
  • b - Microbiology Research Unit, Division of Oral Biosciences, Dublin Dental University Hospital, University of Dublin, Trinity College Dublin, Lincoln Place, Dublin 2, Ireland
  • c - Department of Microbiology, University of Dublin, Trinity College Dublin, Dublin 2, Ireland

 *Acknowledgements:  We thank T. Johnson, Qlean Enterprises, LLC, for providing, installing and commissioning the Clarentis Ultra-Lyte Mini-UL-75a ECA generator used in this study.

Click here to view the study.





CLARENTIS® Intellectual Property Update

September 23, 2016. CLARENTIS received notice from the Intellectual Property Office of Singapore that its patent application No. 201201040-1, Van Kalken/Waldner, was issued on September 2, 2016, as “System and Method for preparation of antimicrobial Solution”.

With equipment installed in Africa and Europe, CLARENTIS is expanding its foreign operations to the Middle East, Hong Kong, Indonesia, Malaysia and Thailand.




October 1, 2016

CLARENTIS announces the launch of the ECO MINI, a more economical version of the Clarentis Mini-Lyte 75. The ECO MINI is able to produce CLARENTIS’s EPA registered medical/hospital disinfectant Ultra-Lyte®.


Ultra-Lyte® shown to inactivate live human norovirus

Poster Presentation Guide. NoroCORE Full Collaborative & Stakeholders Meeting
April 13-15, 2016 in Crystal City, VA* and IAFP, St. Louis, August 2, 2016

Ultra-Lyte®, ECA anolyte or NEW, has been shown by noroCore (  to inactivate live human norovirus.  At this time, Clarentis Ultra-Lyte© is the only substance tested, that is known to do so*.

*    Electrolyzed water inactivates human norovirus; impact on viral structure and function. Moorman E., Montazeri-Djouybari N., and Jaykus L.-A. Department of Food, Bioprocessing & Nutrition Sciences, North Carolina State University, Raleigh, NC. International Association for Food Protection, St. Louis, August 2, 2016.


CLARENTIS® Intellectual Property Update

May 24th, 2016

The United States Patent Office has issued US patent application13/092,653, Van Kalken/Waldner, “System and Method for preparation for antimicrobial solutions”, as US 9,347,140.

In addition, CLARENTIS has made a new patent application, “Van Kalken/Waldner, 15/162,076,  “Cell and System for the preparation of antimicrobial Solutions”, a divisional application of 14/694,334.

CLARENTIS has four patents issued in the United States that protect its proprietary ECA Technology and that allows the company to manufacture ECA equipment to generate stabile hypochlorous acid (HOCl) cleaning, sanitizing and disinfecting solutions, with an extraordinary good salt conversion.

A sample of applications for CLARENTIS ECA Technology that require a minimum use of salt:

Agriculture, Animal Husbandry, Beverage Industry, Borehole remediation, Dairy, Healthcare, Food Processing, Hospitality, Mold Remediation, Oil & Gas, Pharmaceutical Industry and Waste water treatment.